TJX Companies Other Income (Expense) increased by 28.6% to $36.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 62.5%, from $96.00M to $36.00M. Over 4 years (FY 2022 to FY 2026), Other Income (Expense) shows an upward trend with a -9.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.69M | -$28.66M | -$20.67M | -$86.00M | -$19.00M | -$11.00M | $1.00M | -$122.00M | $37.00M | $38.00M | $41.00M | $31.00M | $50.00M | $46.00M | $43.00M | $96.00M | $30.00M | $27.00M | $28.00M | $36.00M |
| QoQ Change | — | +35.9% | +27.9% | -316.0% | +77.9% | +42.1% | +109.1% | <-999% | +130.3% | +2.7% | +7.9% | -24.4% | +61.3% | -8.0% | -6.5% | +123.3% | -68.8% | -10.0% | +3.7% | +28.6% |
| YoY Change | — | — | — | — | +57.5% | +61.6% | +104.8% | -41.9% | +294.7% | +445.5% | >999% | +125.4% | +35.1% | +21.1% | +4.9% | +209.7% | -40.0% | -41.3% | -34.9% | -62.5% |